Pallas Health vs bmiMD: Clinician-chosen brand or subscription tirzepatide
Quick verdict: Pallas Health suits people who want a clinician to choose between FDA-approved Wegovy, Ozempic, Zepbound or Mounjaro and a compounded option; bmiMD targets shoppers focused on lower long-term monthly cost for compounded tirzepatide with multi-month plans and free shipping.
How Pallas Health vs bmiMD differ at a glance
This Pallas Health vs bmiMD comparison focuses on the most distinctive supported differences: medication mix and clinician choice, pricing and billing structure, shipping and refill access, clinician availability and refund/eligibility terms. All statements below preserve each provider’s qualifiers exactly as supplied.
1. Medication options and clinician role
Pallas Health: A US-licensed clinician reviews your health history and personalizes the plan, offering FDA-approved Wegovy, Ozempic, Zepbound and Mounjaro or compounded semaglutide and tirzepatide prepared in the USA when a brand medication is not the right fit. Pallas does not manufacture or compound medication; compounded medicines are prepared by US-licensed compounding pharmacies.
bmiMD: Offers compounded tirzepatide (GLP-1/GIP) with medication prepared in a state-licensed pharmacy; treatment is available only when a licensed clinician determines it is medically appropriate. Both providers note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
2. Pricing and billing model
Pallas prices compounded semaglutide $139 first month, then $597 every 12 weeks (a $199/mo average); compounded tirzepatide is $179 first month, then $897 every 12 weeks (a $299/mo average). Pallas also lists cash-pay brand-name prices: Wegovy $1,349/mo cash-pay, Zepbound $1,069/mo cash-pay, Ozempic $1,299/mo cash-pay and Mounjaro $1,349/mo cash-pay. Pallas states that compounded plans are priced by medication rather than by milligram so titrating up does not raise the plan price.
bmiMD lists four billing options for compounded tirzepatide with lower long-term monthly equivalents: monthly $179, 3-month $159/mo, 6-month $149/mo and 12-month $139/mo. bmiMD promotes that the lowest price requires a 12-month commitment and that the total prepaid charge should be confirmed.
3. Shipping, refills and access
Pallas: Free expedited and discreet shipping is listed on every plan and Pallas offers a self-serve portal for refills, plan changes and provider messaging plus a free companion app. Pallas emphasizes provider care is included in the plan price with no membership fee.
bmiMD: Free subscription shipping on every order is captured, and bmiMD highlights online refills and delivery plus 24/7 clinician access. bmiMD also emphasizes that medication is delivered to your door and confirmed every 3–6 months to stay within ± 10% of target strength.
4. Clinician availability and eligibility/refund terms
Pallas: Eligibility is determined by a US-licensed clinician. Pallas notes care-team hours are weekdays 9 AM–5 PM ET, no emergency services are offered, and treatment is cash-pay only; FSA/HSA use needs a Letter of Medical Necessity. Pallas also states a full refund is provided if a clinician decides treatment is not right for you.
bmiMD: Treatment and eligibility are subject to the live offer and a licensed clinician determining medical appropriateness. bmiMD states 100% Risk Free and 100% Refundable if not eligible for the program, and flags that the lowest monthly equivalent comes with a longer commitment.
Side-by-side comparison
| Criteria | Pallas Health | bmiMD |
|---|---|---|
| Medication mix | FDA-approved brand options plus compounded semaglutide and tirzepatide | Compounded tirzepatide only (GLP-1/GIP) |
| Starting price (compounded) | Semaglutide $139 first month; tirzepatide $179 first month | Tirzepatide $179 monthly; multi-month plans down to $139/mo |
| Long-term billing | Compounded renewals every 12 weeks (e.g. $597 per 12 weeks for semaglutide) | 1, 3, 6 or 12-month plans with lower monthly equivalents for longer terms |
| Shipping and refills | Free expedited and discreet shipping; self-serve portal | Free subscription shipping; online refills and delivery |
| Clinician access and hours | US-licensed clinician review; care-team weekdays 9 AM–5 PM ET | 24/7 clinician access promoted; eligibility subject to clinician review |
| Refunds/eligibility | Refunded in full if clinician decides treatment is not right for you | 100% Risk Free. 100% Refundable if not eligible for program |
Check Pallas Health medication choices
Practical takeaways
If you want a single intake that can result in either an FDA-approved brand-name pen or a clinician-personalized compounded preparation, Pallas Health explicitly positions that clinician-led choice and includes provider care in the plan price. If your priority is the lowest possible monthly equivalent for compounded tirzepatide and you are willing to commit to a multi-month plan, bmiMD advertises multi-month pricing down to $139/month and free shipping.
Conclusion
In choosing between Pallas Health vs bmiMD, pick based only on the supported differences: Pallas Health if you want a clinician to weigh brand-name FDA-approved GLP-1s against a compounded option and prefer provider care included with free expedited shipping; bmiMD if your priority is lower long-term monthly equivalent for compounded tirzepatide with multi-month commitments and free subscription shipping.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →